/

Companies / Tessera Therapeutics

Tessera Therapeutics

Somerville, MA, United States

Tessera Therapeutics is pioneering Gene Writing, a new approach to genome engineering designed to treat diseases at their source

Its latest round on record is Series A, 8 Oct 2025.

Funding

1 round on record
Latest roundSeries A8 Oct 2025
Since that round1 year 1 monthno later round on record
Investors in its rounds1none with a VCinfo profile yet
Oct 2025Series ALed by ARPA-H

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

none on file yet

No investor VCinfo tracks lists Tessera Therapeutics yet.

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Tessera Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when an investor you follow adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/tesseratx.com/investors

# also
GET /v1/companies/tesseratx.com
GET /v1/companies/tesseratx.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing